dexamethasone 21-phosphate has been researched along with Compensatory Hyperinsulinemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, VL; Fowden, AL; Holdstock, NB; Jellyman, JK; Valenzuela, OA | 1 |
| Boschero, AC; Bosqueiro, JR; Paula, FM; Quallio, S; Rafacho, A; Ribeiro, DL; Taboga, SR | 1 |
1 trial(s) available for dexamethasone 21-phosphate and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
Effects of maternal dexamethasone treatment on pancreatic β cell function in the pregnant mare and post natal foal.
Topics: Animals; Animals, Newborn; Dexamethasone; Female; Horses; Hyperinsulinism; Insulin; Insulin-Secreting Cells; Pregnancy | 2017 |
1 other study(ies) available for dexamethasone 21-phosphate and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
The adaptive compensations in endocrine pancreas from glucocorticoid-treated rats are reversible after the interruption of treatment.
Topics: Adaptation, Physiological; Animals; Blood Glucose; Cell Cycle Proteins; Cell Death; Cell Proliferation; Dexamethasone; Drug Administration Schedule; Glucocorticoids; Glucose Intolerance; Hyperinsulinism; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Islets of Langerhans; Male; Rats; Rats, Wistar; Time Factors | 2010 |